학술논문
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2020, Vol. 16 Issue 9, p2265-2273, 9p
Subject
Language
ISSN
21645515